Hormonal regulation of rat renal cytochrome P450s by androgen and the pituitary

doi:10.1016/0003-9861(92)90260-4

Archives of Biochemistry and Biophysics

Volume 299, Issue 1, 15 November 1992, Pages 179-184

https://doi.org/10.1016/0003-9861(92)90260-4 Get rights and content

Abstract

The hormonal regulation of rat renal cytochrome P450s, P450 4A2 (K-5) and K-2, was investigated. The level of P450 4A2 in male rats was five times that in female rats and accounted for some 90% of total cytochrome P450, measured photometrically. Lauric acid ω-and (ω-1)-hydroxylation activities of renal microsomes of male rats were also higher than those of female rats. The sex differences in lauric acid hydroxylation activity seemed to arise from the differences in P450 4A2 concentrations, according to an immunochemical study. P450 K-2 was a female-dominant form in rat kidneys. The level of P450 K-2 in renal microsomes of male rats was one-tenth that of P450 4A2. Castration of male rats decreased the levels of P450 4A2 and treatment of castrated male rats with testosterone reversed the decrease. The castration of male rats decreased the lauric acid hydroxylation of the renal microsomes to the level of female rats. The administration of testosterone to castrated male rats reversed the decrease. Hypophysectomy of male rats decreased the level of P450 4A2 and the administration of growth hormone reversed the decrease when intermittent injections mimicking the male secretory pattern were given, although continuous administration mimicking the female secretory pattern did not. Castration of male rats did not affect the level of P450 K-2, but testosterone decreased its level. Hypophysectomy of male rats increased the level of P450 K-2 and growth hormone decreased its level in hypophysectomized rats. These results suggested that the expression of P450 4A2 was regulated by androgen or growth hormone and regulation of P450 4A2 was different from that of P450 K-2. To explore the regulation of renal cytochrome P450 further, testosterone was given to control (intact) or hypophysectomized adult female rats. P450 4A2 was induced in the kidneys of both control and hypophysectomized female rats to close to the level of male rats. Thus, P450 4A2 was directly regulated by testosterone as well as growth hormone, and the regulation of the male-dominant form in rat kidneys was different from that of the male-specific form in the rat liver, which is regulated mostly by growth hormone.

References (31)

T. Kamataki et al.
Arch. Biochem. Biophys
(1983)
Y. Yamazoe et al.
J. Biol. Chem
(1987)
P.D. McClellan-Green et al.
J. Biol. Chem
(1989)
S. Imaoka et al.
Arch. Biochem. Biophys
(1990)
S. Mohla et al.
Biochem. Pharmacol
(1988)
S.S. Sundseth et al.
J. Biol. Chem
(1992)
J.P. Hardwick et al.
J. Biol. Chem
(1987)
M.L. Schwartzman et al.
J. Biol. Chem
(1989)
S. Imaoka et al.
Biochim. Biophys. Acta
(1991)
S. Imaoka et al.
Arch. Biochem. Biophys
(1990)

O.H. Lowry et al.

J. Biol. Chem

(1951)

T. Omura et al.

J. Biol. Chem

(1964)

G.A. Dannan et al.

J. Biol. Chem

(1986)

S. Imaoka et al.

Biochem. Biophys. Res. Commun

(1988)

S. Imaoka et al.

Biochim. Biophys. Acta

(1990)

Cited by (41)

Renal Xenobiotic Metabolism
2018, Comprehensive Toxicology: Third Edition
The kidney possess most of the common drug-metabolising enzymes, and thus is able to make an important contribution to the body’s metabolism of drugs and other xenobiotics. The catalytic activity of the various enzymes is lower than in the liver, however enzymes involved in the processing of GSH conjugates to their mercapturic acids primarily involves the kidney. Xenobiotic-metabolising enzymes are not evenly distributed along the nephron: cytochromes P450 and enzymes involved in conjugation, glucuronidation or sulfation are present in higher concentrations in proximal tubular cells then other regions. There are however exception where some isoenzymes of P450 and GST’s are selectively localized in cells of the thick ascending limb. Most of the major form of cytochrome P450 are detected in the kidneys of experimental animals and humans. However, members of the CYP1 family, CYP2D6 and CYP2E1 appear to be, absent in human kidney. GST’s have been most extensively characterised in rat and humans kidney. The renal enzyme cysteine conjugate β-lyase involved in the bioactivation of haloalkane and haloalkene S-conjugates have been cloned and sequenced from both rat and human kidney and shown to be identical to glutamine transaminase K and KAT. Cloning approaches have also demonstrated the presence in the kidney of multiple forms of UGT, flavin monooxygenases, CES and SULTS. Bioactivation of certain chemicals by SULTS can generate reactive metabolites that modify DNA and leads to renal cancer. All of the enzymes discussed in addition to detoxification of foreign chemicals, and in a few case causing bioactivation have endogenous functions in the body. Such as regulation of salt and water balance, the control of blood pressure and synthesis of vitamin D and there are many more physiological roles for these enzymes awaiting discovery.
20-HETE in neovascularization
2012, Prostaglandins and Other Lipid Mediators
Citation Excerpt :
However, Cyp4a10 was found in the kidneys of all mice [29]. The main isoforms in rats [32] were CYP4A1 [32–36] and CYP4A2 [37–40], which also vary by gender. CYP4A protein has been found in the brain, prostate, intestine, and lungs of rat and rabbits [32,41,42].
Cytochrome P450 4A/F (CYP4A/F) converts arachidonic acid (AA) to 20-HETE by ω-hydroxylation. The contribution of 20-HETE to the regulation of myogenic response, blood pressure, and mitogenic actions has been well summarized. This review focuses on the emerging role of 20-HETE in physiological and pathological vascularization. 20-HETE has been shown to regulate vascular smooth muscle cells (VSMC) and endothelial cells (EC) by affecting their proliferation, migration, survival, and tube formation. Furthermore, the proliferation, migration, secretion of proangiogenic molecules (such as HIF-1α, VEGF, SDF-1α), and tube formation of endothelial progenitor cells (EPC) are stimulated by 20-HETE. These effects are mediated through c-Src- and EGFR-mediated downstream signaling pathways, including MAPK and PI3K/Akt pathways, eNOS uncoupling, and NOX/ROS system activation. Therefore, the CYP4A/F-20-HETE system may be a therapeutic target for the treatment of abnormal angiogenic diseases.
Validation of housekeeping genes as internal controls for studying biomarkers of endocrine-disrupting chemicals in disk abalone by real-time PCR
2011, Comparative Biochemistry and Physiology - C Toxicology and Pharmacology
Citation Excerpt :
The expression of abalone CYP4 was highly induced after 7 days waterborne exposure to TBT in gill but only slightly up-regulated in hepatopancreas, indicating that our challenge possibly caused acute oxidative stress in gill tissue that comes into directly contact with chemicals. On the other hand, if our challenge could be long term (> 30 days), TBT might be accumulated in hepatopancreas and alter the levels of circulating androgens that would induce the expression of CYP4 as well (Imaoka et al., 1992). Compared to TBT, the exposure to E2 produced a weak effect on CYP4 expression in both tissues (≤ 0.5 fold-change).
Our experiments were designed to identify suitable housekeeping genes (HKGs) in disk abalone as internal controls to quantify biomarker expression following endocrine disrupting chemicals (EDCs). Relative expression levels of twelve candidate HKGs were examined by real-time reverse transcription PCR (qRT-PCR) in gill and hepatopancreas of abalone following a 7-day challenge with either tributyltin chloride (TBT) or 17β-estradiol (E2). The expression levels of several conventional HKGs, such as 18s rRNA, glyceraldehyde-3-phosphate dehydrogenase and β-actin, were significantly altered by the challenges, indicating that they might not be suitable internal controls. Instead, the geNorm analysis pinpointed ribosomal protein L-5/ elongation factor 1 and ribosomal protein L-5/ succinate dehydrogenase as the most stable HKGs under TBT and E2 challenges, respectively. Moreover, these three HKGs also showed the highest stabilities overall amongst different tissues, genders and EDC challenges. The expression of a biomarker gene, cytochrome P450 4B (CYP4), was also investigated and exhibited a significant increase after the challenges. Importantly, when unsuitable HKGs were used for normalization, the influence of two EDCs on CYP4 expression was imprecisely overestimated or underestimated, which strongly emphasized the importance of selecting appropriately validated HKGs as internal controls in biomarker studies.
Renal Xenobiotic Metabolism
2010, Comprehensive Toxicology, Second Edition
All of the common drug-metabolizing enzymes involved in phase 1 and phase 2 metabolism of xenobiotics are present in the kidney, although the catalytic activity of the various enzymes in the whole kidney is lower than that in the liver. Renal drug-metabolizing enzymes are, however, not evenly distributed along the nephron; cytochrome’s P450 and enzymes involved in conjugation with glutathione (GSH), glucuronic acid, or sulfate are present at much higher concentrations in cells of the proximal tubule than in other parts of the nephron, and thus comparison on a whole organ basis underestimates renal cell activity. Hence, the proximal tubule is the principal site of xenobiotic biotransformation and is particularly susceptible to chemical insult, while the localization of prostaglandin H-synthase (PHS) to the inner medulla and papilla may be a contributory factor to the toxicity produced by chemicals in this part of the nephron.
Many xenobiotic-biotransformation enzymes have been cloned and sequenced, and their presence in the kidney detected. Most of the major families of cytochrome P450 involved in xenobiotic metabolism have been detected in the kidneys of experimental animals and humans. Members of the CYP2B subfamily appear to be absent from rat and mouse kidney but present in the rabbit and hamster. The CYP4A subfamily involved in ω and ω–1 oxidation of fatty acids and arachidonic acid (AA) are expressed at particularly high levels in the kidney and are involved in the side chain metabolism of many drugs and xenobiotics. Glutathione S-transferases (GSTs) have been most extensively characterized in rat and human kidney, this tissue having a different subunit profile from that of the liver, with a predominance of A (alpha) and P1-1 (pi) classes. Cloning has identified a number of relatively new forms of GSTs, and although these enzymes are mainly located in the cytosol, some are associated with microsomes and mitochondria. The kidney plays a pivotal role in the processing of GSH conjugates to their cysteine conjugates and then mercapturic acids for excretion in urine. The renal enzyme cysteine conjugate β-lyase involved in the bioactivation of haloalkane and haloalkene S-cysteine conjugates has been cloned and sequenced from both rat and human kidney, and is shown to be identical to glutamine transaminase K and kynurenine aminotransferase. Cloning approaches have also demonstrated the presence in the kidney of multiple forms of UDP-glucuronosyltransferase, flavin monooxygenase, carboxylesterase, and sulfotransferase
The presence and localization of xenobiotic biotransformation enzymes in human kidney are still limited, although information on embryonic and fetal tissue is beginning to emerge. Many of the enzymes discussed, in addition to their ability to metabolize drugs or foreign compounds, have endogenous functions in the kidney, for instance, in the regulation of salt and water balance, the control of blood pressure and inflammation, and the synthesis of vitamin D.
Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: High glucose suppresses sEH expression
2009, Drug Metabolism and Pharmacokinetics
Soluble epoxide hydrolase (sEH) is a xenobiotic-metabolizing enzyme that metabolizes epoxides to produce vicinal diols. Diabetes is a common pathological condition which effects drug metabolism. This study, investigates changes in the levels of sEH in mice with diabetes induced by streptozotocin (STZ). Diabetes reduced the amount of sEH protein in the liver and insulin restored the level of protein. The kidneys are a target of diabetes. Diabetes significantly decreased levels of sEH protein and also mRNA. The distribution of sEH in the kidney was studied with immunostaining. There was distinct staining in the proximal tubules but not in the glomerulus or other regions. Diabetes is characterized by high glucose concentrations that lead to increased production of reactive oxygen species (ROS). High glucose suppressed sEH mRNA and protein expression in Hep3B cells. NADPH oxidase is the main source of ROS generation in high glucose condition. The NADPH oxidase inhibitor, diphenyleneiodonium chloride (DPIC), inhibited decrease in sEH expression at high glucose and hydrogen peroxide suppressed sEH expression. These findings indicate that diabetes reduces sEH expression by inducing ROS and may have important effects on the metabolism of xenobiotics and endogenous substrates of sEH.
Conditional regulation of the human CYP4X1 and CYP4Z1 genes
2005, Archives of Biochemistry and Biophysics
Cytochrome P450 genes (CYPs) encoding two new subfamilies designated CYP4X1 and CYP4Z1 were identified in the human genome and the Expressed Sequence Tags database. Partial cDNAs encoding both P450s were isolated from human kidney and used to determine tissue distribution. CYP4X1 was predominantly expressed in trachea and aorta, whereas CYP4Z1 mRNA was preferentially expressed in mammary tissue. In T47-D cells, CYP4Z1 mRNA levels were induced by dexamethasone (14-fold) or by progesterone (10-fold). The induction by these compounds was suppressed by co-treatment with the progesterone and glucocorticoid receptor antagonist mifepristone (RU486). In the progesterone receptor negative MCF-7 cells, CYP4Z1 mRNA was induced by dexamethasone but not by progesterone treatment. CYP4Z1 mRNA levels were unaffected by 17β-estradiol. In confluent cultures of human hepatoma HepG2 cells that stably express a mouse peroxisome proliferator activated receptor-α (PPARα) mutant, CYP4X1 mRNA was undetectable in vehicle-treated cells but was readily detectable following addition of the PPARα agonist Wy14643. This suggests that PPARα activation can affect human CYP4X1 gene transcription. These results demonstrate selective tissue expression and implicate PPARα in CYP4X1 regulation, and the glucocorticoid and progesterone receptors in CYP4Z1 gene activation.

View all citing articles on Scopus

View full text

Hormonal regulation of rat renal cytochrome P450s by androgen and the pituitary

Abstract

Arch. Biochem. Biophys

J. Biol. Chem

J. Biol. Chem

Arch. Biochem. Biophys

Biochem. Pharmacol

J. Biol. Chem

J. Biol. Chem

J. Biol. Chem

Biochim. Biophys. Acta

Arch. Biochem. Biophys

J. Biol. Chem

J. Biol. Chem

J. Biol. Chem

Biochem. Biophys. Res. Commun

Biochim. Biophys. Acta